Cognetivity Neurosciences is a Platform technology for early, rapid and easy detection of dementia.
Cognetivity Neurosciences has raised $3.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2022.
Cognetivity Neurosciences's investors include Innovate UK, Rockshield Capital.
Cognetivity Neurosciences is headquartered in West Point, United States.
Cognetivity Neurosciences is a Platform technology for early, rapid and easy detection of dementia.
Cognetivity Neurosciences is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cognetivity Neurosciences — Funding & Investors." VCBacked, October 27, 2022, https://www.vcbacked.co/company/cognetivity-neurosciences. Accessed September 30, 2026.
VCBacked. (2022). Cognetivity Neurosciences — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/cognetivity-neurosciences
{{cite web |title=Cognetivity Neurosciences — Funding & Investors |url=https://www.vcbacked.co/company/cognetivity-neurosciences |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated